All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F17%3A10361763" target="_blank" >RIV/00216208:11110/17:10361763 - isvavai.cz</a>

  • Alternative codes found

    RIV/00064165:_____/17:10361763

  • Result on the web

    <a href="http://dx.doi.org/10.1007/s10545-016-9979-0" target="_blank" >http://dx.doi.org/10.1007/s10545-016-9979-0</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1007/s10545-016-9979-0" target="_blank" >10.1007/s10545-016-9979-0</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency

  • Original language description

    Cystathionine beta-synthase (CBS) deficiency is a rare inherited disorder in the methionine catabolic pathway, in which the impaired synthesis of cystathionine leads to accumulation of homocysteine. Patients can present to many different specialists and diagnosis is often delayed. Severely affected patients usually present in childhood with ectopia lentis, learning difficulties and skeletal abnormalities. These patients generally require treatment with a low-methionine diet and/or betaine. In contrast, mildly affected patients are likely to present as adults with thromboembolism and to respond to treatment with pyridoxine. In this article, we present recommendations for the diagnosis and management of CBS deficiency, based on a systematic review of the literature. Unfortunately, the quality of the evidence is poor, as it often is for rare diseases. We strongly recommend measuring the plasma total homocysteine concentrations in any patient whose clinical features suggest the diagnosis. Our recommendations may help to standardise testing for pyridoxine responsiveness. Current evidence suggests that patients are unlikely to develop complications if the plasma total homocysteine concentration is maintained below 120 mu mol/L. Nevertheless, we recommend keeping the concentration below 100 mu mol/L because levels fluctuate and the complications associated with high levels are so serious.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30202 - Endocrinology and metabolism (including diabetes, hormones)

Result continuities

  • Project

  • Continuities

    N - Vyzkumna aktivita podporovana z neverejnych zdroju

Others

  • Publication year

    2017

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Journal of Inherited Metabolic Disease

  • ISSN

    0141-8955

  • e-ISSN

  • Volume of the periodical

    40

  • Issue of the periodical within the volume

    1

  • Country of publishing house

    NL - THE KINGDOM OF THE NETHERLANDS

  • Number of pages

    26

  • Pages from-to

    49-74

  • UT code for WoS article

    000391132500005

  • EID of the result in the Scopus database

    2-s2.0-84992205928